Market Overview The Adenomyosis Market is innovating as non-invasive ablation technologies and uterine-sparing interventions reduce reliance on hysterectomy for symptom control. The Adenomyosis Market is projected to grow through 2030, driven by high-intensity focused ultrasound adoption, uterine artery embolization refinement, magnetic resonance-guided therapy, and cryoablation development...